These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3660333)

  • 1. Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect.
    De Stefano V; Leone G; De Carolis MP; Ferrelli R; De Carolis S; Pagano L; Tortorolo G; Bizzi B
    Thromb Haemost; 1987 Jun; 57(3):329-31. PubMed ID: 3660333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin III molecular variants with defective binding to heparin or to serine proteases: evidence of two different abnormal patterns identified by crossed immunoelectrofocusing.
    Leone G; De Stefano V; Ferrelli R; Teofili L; Tengborn L; Vahtera E; Bizzi B
    Thromb Haemost; 1988 Aug; 60(1):8-12. PubMed ID: 3187949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin III loss in patients with nephrotic syndrome or receiving continuous ambulatory peritoneal dialysis. Evidence of inactive antithrombin III in urine of patients with nephrotic syndrome.
    De Stefano V; Triolo L; De Martini D; Ferrelli R; Mori R; Leone G
    J Lab Clin Med; 1987 May; 109(5):550-5. PubMed ID: 3572202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Levels of antithrombin III and proteins C in the newborn infant].
    Abad A; Marco Vera P; Mompel A; García Pérez A
    Sangre (Barc); 1989 Apr; 34(2):91-5. PubMed ID: 2756455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AT III Barcelona: a familial quantitative-qualitative AT III deficiency.
    Grau E; Fontcuberta J; Félez J; de Diego I; Soto R; Rutllant ML
    Thromb Haemost; 1988 Feb; 59(1):13-7. PubMed ID: 3363529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III Alger: a new homozygous AT III variant.
    Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M
    Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and functional study of antithrombin III in newborn infants.
    McDonald MM; Hathaway WE; Reeve EB; Leonard BD
    Thromb Haemost; 1982 Feb; 47(1):56-8. PubMed ID: 7071806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic studies of antithrombin III heparin cofactor in the newborn.
    Hathaway WE; Neumann LL; Borden CA; Jacobson LJ
    Thromb Haemost; 1978 Jun; 39(3):624-30. PubMed ID: 705691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tentative classification of AT III congenital abnormalities.
    Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):661-9. PubMed ID: 2448207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of the "classical" antithrombin III deficiency.
    Sas G; Petö I; Bánhegyi D; Blaskó G; Domján G
    Thromb Haemost; 1980 Jun; 43(2):133-6. PubMed ID: 7455972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunctional antithrombin III in sick premature infants.
    Andrew M; Massicotte-Nolan P; Mitchell L; Cassidy K
    Pediatr Res; 1985 Feb; 19(2):237-9. PubMed ID: 3982886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard assays underestimate the concentration of heparin in neonatal plasma.
    Schmidt B; Mitchell L; Ofosu F; Andrew M
    J Lab Clin Med; 1988 Nov; 112(5):641-3. PubMed ID: 3183496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated protein C resistance in cord blood from healthy and complicated newborns.
    Gursel T; Kocak U; Kaya Z; Bukulmez A; Atalay Y
    J Matern Fetal Neonatal Med; 2007 Nov; 20(11):797-801. PubMed ID: 17853185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization of a pathological isoantithrombin with no affinity for heparin (antithrombin III Roma).
    De Stefano V; Leone G; Ferrelli R; Di Donfrancesco A; De Martini D; Bizzi B
    Thromb Res; 1987 Oct; 48(1):23-30. PubMed ID: 3424283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intrauterine infection and perinatal risk factors on serum concentrations of insulin like growth factor (IGF-I) in full-term and preterm newborns.
    Oświecimska JM; Stojewska M; Behrendt J; Pikiewicz-Koch A; Ziora KT; Szczepanska M; Barc-Czarnecka M; Godula-Stuglik U
    Neuro Endocrinol Lett; 2008 Apr; 29(2):222-9. PubMed ID: 18404140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microheterogeneity of antithrombin III: effect of single amino acid substitutions and relationship with functional abnormalities.
    De Stefano V; Leone G; Mastrangelo S; Lane DA; Girolami A; de Moerloose P; Sas G; Abildgaard U; Blajchman M; Rodeghiero F
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):7-15. PubMed ID: 8180341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
    Howarth DJ; Samson D; Stirling Y; Seghatchian MJ
    Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of red cells and plasma to blood viscosity in preterm and full-term infants and adults.
    Linderkamp O; Versmold HT; Riegel KP; Betke K
    Pediatrics; 1984 Jul; 74(1):45-51. PubMed ID: 6204271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited antithrombin III deficiency and cerebral thrombosis in a child.
    Ambruso DR; Jacobson LJ; Hathaway WE
    Pediatrics; 1980 Jan; 65(1):125-31. PubMed ID: 7355006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin III Pescara: a defective AT III variant with no alterations of plasma crossed immunoelectrophoresis, but with an abnormal crossed immunoelectrofocusing pattern.
    Leone G; De Stefano V; Di Donfrancesco A; Ferrelli R; Traisci G; Bizzi B
    Br J Haematol; 1987 Feb; 65(2):187-91. PubMed ID: 3828226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.